Clinical Trial Update: Study of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital Warts [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating efficacy and safety of Ingaron (Interferon-gamma) for anogenital warts due to HPV; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anogenital Warts
• Human Papillomavirus Infection

Drugs mentioned

• Ingaron (Interferon-gamma)

Snippet

Sponsor: SPP Pharmaclon Ltd. | Conditions: Human Papillomavirus Infection, Anogenital Warts | Phase 3 | Status: COMPLETED